These shares are starting the week on a positive note. But why? The post Why Ansell, GQG, Mayne Pharma, and Star shares are ...

Novo Nordisk boasts 45 million customers using its drug, which has caused a revolution in weight-loss treatment. But competitors are nipping at its heels.

Stocks including LIC, Bharat Electronics, Vedanta, Glenmark Pharma, Cipla, FirstCry, NHPC, VA Tech Wabag and more will be in ...

Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's ...

Wedgewood, a veterinary compounding pharmacy, has appointed Benjamin Daniels, JD, MPP, as its general counsel and chief ...

Recognizing Siegel’s importance as an employee and a respected figure among Israeli psychiatrists, Lundbeck Global took ...

Ansell has moved to expand its manufacturing presence beyond China, to countries including India and Sri Lanka.

The tussle between IHH Healthcare Bhd, Asia’s biggest private healthcare provider, and Daiichi Sankyo Co Ltd, a ...

Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

Most of the commercials airing during this year's Super Bowl are going for laughs, with advertisers betting that America ...

Medical misogyny is real, but a campaign about women’s pain – if that’s what it is – sponsored by a painkiller company seems ...

Summit Minerals (ASX:SUM) has appointed Dr Matthew Cobb as CEO to lead the company’s Equador niobium and rare earths project ...